Nukkleus DFNS

Nukkleus Q2 FY24: revenue $260K; diluted EPS −$0.17

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Nukkleus reported for Q2 FY24, the quarter ended Mar 31, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$260KNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income−$2.4MNo year-earlier figure tagged10-Q income statement, on EDGAR
  3. Diluted EPS−$0.17No year-earlier figure tagged10-Q income statement, on EDGAR
  4. Cash and cash equivalents$306KNo year-earlier figure tagged10-Q balance sheet, on EDGAR
  5. Cash from operations−$1.1MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR

Every quarter in the financial tables

Get an email when Nukkleus files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8742 and related industry codes: the same peer list as the financial tables.